S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

CVKD Cadrenal Therapeutics Inc

15.00

0.51 (3.52%)

03 Jan 2025 - Closed

Delayed by 15 minutes

Form D - Notice of Exempt Offering of Securities

Cadrenal Therapeutics (NASDAQ:CVKD)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Cadrenal Therapeutics Charts.

Cadrenal Therapeutics (NASDAQ:CVKD)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Cadrenal Therapeutics Charts.

Cadrenal Therapeutics Inc News

Cadrenal Therapeutics Provides 2024 Year-End Company Update, Reinforcing Clinical Development Plan for Tecarfarin in LVAD and Other Rare Cardiovascular Indications
Wednesday 1 January 2025 (3 days ago) • Business Wire

Form S-8 - Securities to be offered to employees in employee benefit plans
Tuesday 24 December 2024 (1 week ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Saturday 21 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Cadrenal Therapeutics Gears Up for the 43rd Annual J.P. Morgan Healthcare Conference Week with Event Participation and Investor/Partner Meetings
Thursday 19 December 2024 (2 weeks ago) • Business Wire

Form 424B3 - Prospectus [Rule 424(b)(3)]
Tuesday 26 November 2024 (1 month ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Monday 25 November 2024 (1 month ago) • Edgar (US Regulatory)

Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook
Wednesday 20 November 2024 (1 month ago) • PR Newswire (US)

Form S-3 - Registration statement under Securities Act of 1933
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS
Wednesday 13 November 2024 (2 months ago) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

CADRENAL THERAPEUTICS PROVIDES THIRD-QUARTER CORPORATE UPDATE
Friday 8 November 2024 (2 months ago) • PR Newswire (US)

More Cadrenal Therapeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions